1 / 36

Presented By Alan Venook at 2014 ASCO Annual Meeting

<br />CALGB/SWOG 80405: Phase III trial of FOLFIRI or FOLFOX with Bevacizumab or Cetuximab for patients w/ KRAS wild type untreated metastatic adenocarcinoma of the colon or rectum <br />. Presented By Alan Venook at 2014 ASCO Annual Meeting. Slide 2.

juliet
Télécharger la présentation

Presented By Alan Venook at 2014 ASCO Annual Meeting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. <br />CALGB/SWOG 80405: Phase III trial of FOLFIRI or FOLFOX with Bevacizumab or Cetuximab for patients w/ KRAS wild type untreated metastatic adenocarcinoma of the colon or rectum <br /> Presented By Alan Venook at 2014 ASCO Annual Meeting

  2. Slide 2 Presented By Alan Venook at 2014 ASCO Annual Meeting

  3. CALGB/SWOG 80405: <br /> FINAL DESIGN Presented By Alan Venook at 2014 ASCO Annual Meeting

  4. COLORECTAL CANCER IN 2004 <br /> IS THERE AN OPTIMAL 1ST LINE TREATMENT ? Presented By Alan Venook at 2014 ASCO Annual Meeting

  5. 2004: A lot can happen in 10 years Presented By Alan Venook at 2014 ASCO Annual Meeting

  6. CALGB / SWOG 80405: <br /> WHY DID IT TAKE TEN YEARS? Presented By Alan Venook at 2014 ASCO Annual Meeting

  7. CALGB/SWOG 80405: Eligibility Criteria Presented By Alan Venook at 2014 ASCO Annual Meeting

  8. CALGB/SWOG 80405: Endpoints Presented By Alan Venook at 2014 ASCO Annual Meeting

  9. CALGB/SWOG 80405: Statistics Presented By Alan Venook at 2014 ASCO Annual Meeting

  10. CALGB/SWOG 80405: Statistics Presented By Alan Venook at 2014 ASCO Annual Meeting

  11. Slide 11 Presented By Alan Venook at 2014 ASCO Annual Meeting

  12. Slide 12 Presented By Alan Venook at 2014 ASCO Annual Meeting

  13. CALGB/SWOG 80405: Overall Survival <br /> Presented By Alan Venook at 2014 ASCO Annual Meeting

  14. CALGB/SWOG 80405: Progression-Free Survival<br />(Investigator Determined) Presented By Alan Venook at 2014 ASCO Annual Meeting

  15. Slide 15 Presented By Alan Venook at 2014 ASCO Annual Meeting

  16. CALGB/SWOG 80405: Overall Survival<br />FOLFOX Treated Presented By Alan Venook at 2014 ASCO Annual Meeting

  17. CALGB/SWOG 80405: Overall Survival<br />FOLFIRI Treated Presented By Alan Venook at 2014 ASCO Annual Meeting

  18. Patients Rendered Disease-Free<br />Overall Survival Presented By Alan Venook at 2014 ASCO Annual Meeting

  19. Grade 3-4 Toxicities<br /> Presented By Alan Venook at 2014 ASCO Annual Meeting

  20. Slide 20 Presented By Alan Venook at 2014 ASCO Annual Meeting

  21. 80405: Data Pending Presented By Alan Venook at 2014 ASCO Annual Meeting

  22. Quality of Life and Symptoms Presented By Alan Venook at 2014 ASCO Annual Meeting

  23. Slide 23 Presented By Alan Venook at 2014 ASCO Annual Meeting

  24. “Expanded RAS” Presented By Alan Venook at 2014 ASCO Annual Meeting

  25. <br /> Correlative Studies<br /> Tumor / Plasma / Serum > 44000 samples<br /> Presented By Alan Venook at 2014 ASCO Annual Meeting

  26. 80405: Upcoming Presentations Presented By Alan Venook at 2014 ASCO Annual Meeting

  27. CALGB/SWOG 80405: Conclusions Presented By Alan Venook at 2014 ASCO Annual Meeting

  28. CALGB/SWOG 80405: Conclusions Presented By Alan Venook at 2014 ASCO Annual Meeting

  29. CALGB/SWOG 80405: Conclusions Presented By Alan Venook at 2014 ASCO Annual Meeting

  30. Slide 30 Presented By Alan Venook at 2014 ASCO Annual Meeting

  31. TAKE HOME MESSAGE Presented By Alan Venook at 2014 ASCO Annual Meeting

  32. Value of publicly funded clinical research Presented By Alan Venook at 2014 ASCO Annual Meeting

  33. ACKNOWLEDGEMENTS / THANKS Collaborators Presented By Alan Venook at 2014 ASCO Annual Meeting

  34. ACKNOWLEDGEMENT / THANK YOU Presented By Alan Venook at 2014 ASCO Annual Meeting

  35. Slide 35 Presented By Alan Venook at 2014 ASCO Annual Meeting

  36. Slide 36 Presented By Alan Venook at 2014 ASCO Annual Meeting

More Related